Clinical presentation and management outcome in patients with malignant eyelid tumors – Observational study at a tertiary care centre in Central India

• Author Details:   
• Snehal Kokode
• Shivani Shadangi ^*

---

Eyelid tumors represent a significant subset of skin cancers, accounting for approximately 5–10% of all cases. This observational study conducted at a tertiary care centre in Central India aims to investigate the clinical presentation and management outcomes of patients with malignant eyelid tumors.

The study encompasses 18 patients diagnosed with malignant eyelid tumors between October 2022 and October 2024. The demographic profile, tumor characteristics, and systemic risk factors were meticulously documented, and primary metastatic evaluations were performed. Surgical management included excision biopsy and lid reconstruction, with wide excision and clear margins confirmed after frozen section. The most common tumor type observed was sebaceous gland carcinoma (SGC), accounting for 55% of cases. The study found no tumor recurrence at a mean follow-up of 12 months.

This research highlights the importance of prompt detection, accurate diagnosis, and comprehensive surgical management in improving patient outcomes and reducing the risk of cosmetic disfigurement and morbidity associated with malignant eyelid tumors.